Choate Investment Advisors Pfizer Inc Transaction History

Choate Investment Advisors

$4.12 Billion
Q4 2024

A detailed history of Choate Investment Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Choate Investment Advisors holds 139,863 shares of PFE stock, worth $3.57 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

139,863

Previous 140,000 0.1%

Holding current value

$3.57 Million

Previous $4.05 Million 8.42%

% of portfolio

0.09%

Previous 0.1%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$24.8 - $30.19 $3,397 - $4,136	-137 Reduced 0.1%	139,863 $3.71 Million
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $132,987 - $150,703	-4,801 Reduced 3.32%	140,000 $4.05 Million
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $35,212 - $41,262	-1,394 Reduced 0.95%	144,801 $4.05 Million
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $403,599 - $463,460	-15,589 Reduced 9.64%	146,195 $4.06 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $50,613 - $65,741	-1,937 Reduced 1.18%	161,784 $4.66 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $732,165 - $855,828	22,816 Added 16.19%	163,721 $5.43 Million
Q2 2023 Aug 01, 2023	BUY	$36.12 - $41.79 $24,236 - $28,041	671 Added 0.48%	140,905 $5.17 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $2,796 - $3,640	71 Added 0.05%	140,234 $5.72 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $405,350 - $529,140	9,709 Added 7.44%	140,163 $7.18 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $111,544 - $136,167	2,549 Added 1.99%	130,454 $5.71 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $96,549 - $114,477	2,075 Added 1.65%	127,905 $6.71 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $10,797 - $13,378	-236 Reduced 0.19%	125,830 $6.51 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $37,601 - $55,737	-910 Reduced 0.72%	126,066 $7.44 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $100,911 - $129,629	-2,571 Reduced 1.98%	126,976 $5.46 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $229,464 - $259,945	-6,390 Reduced 4.7%	129,547 $5.07 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $62,961 - $71,007	-1,880 Reduced 1.36%	135,937 $4.93 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $59,375 - $75,501	-1,774 Reduced 1.27%	137,817 $5.07 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $100,266 - $117,635	-3,158 Reduced 2.21%	139,591 $5.12 Million
Q2 2020 Jul 23, 2020	SELL	$30.12 - $36.54 $217,255 - $263,563	-7,213 Reduced 4.81%	142,749 $4.67 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $54,438 - $77,780	-2,014 Reduced 1.33%	149,962 $4.9 Million
Q4 2019 Jan 28, 2020	SELL	$32.92 - $37.36 $63,338 - $71,880	-1,924 Reduced 1.25%	151,976 $5.95 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $231,458 - $300,134	-7,124 Reduced 4.42%	153,900 $5.53 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $79,396 - $89,143	-2,147 Reduced 1.32%	161,024 $6.98 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $11,062 - $12,154	-295 Reduced 0.18%	163,171 $6.93 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $11,925 - $13,596	-310 Reduced 0.19%	163,466 $7.14 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $659,204 - $799,574	-19,124 Reduced 10.46%	163,776 $7.22 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $112,362 - $119,790	-3,407 Reduced 1.83%	182,900 $6.64 Million
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $33,601 - $38,982	1,053 Added 0.57%	186,307 $0
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $84,846 - $90,024	-2,551 Reduced 1.36%	185,254 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $5.82 Million - $6.41 Million	187,805	187,805 $0

Others Institutions Holding PFE

# of Institutions

3,344

Shares Held

3.69B

Call Options Held

106M

Put Options Held

124M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Account

Choate Investment Advisors Pfizer Inc Transaction History